文献速递脑血管病外科神经重症

动脉瘤性蛛网膜下腔出血后抑郁:筛查工具与出院用户界面的开发

Depression after aneurysmal subarachnoid hemorrhage: development of a screening tool and discharge user interface.
PubMed 文献 · Acta Neurochir (Wien) · 2025-06-24

本研究基于已发表的预测模型,开发了针对aSAH患者治疗后抑郁风险的5分制评分工具(吸烟2分,COPD、糖尿病、非囊状动脉瘤各1分),并在514例单中心患者中验证。结果显示治疗后抑郁发生率为29.6%,中风险组(2-3分)和高风险组(4-5分)的抑郁风险显著增加,同时开发了交互式应用辅助出院咨询。

要点

  • 5分制评分基于吸烟、COPD、糖尿病和非囊状动脉瘤4个特征。
  • 评分1分为低风险,2-3分为中风险,4-5分为高风险。
  • 中风险和高风险组抑郁风险显著高于0分者,低风险组无显著增加。

核心结论

  • 本队列中相当比例的患者在aSAH治疗后出现重性抑郁障碍症状。
  • 一个易于使用的预测和风险分层工具可用于aSAH患者治疗后抑郁的评估。

研究设计与样本

  • 基于已发表的aSAH患者治疗后抑郁风险预测模型,利用最终预测模型的β系数开发5分制量表。
  • 在单中心治疗的514例患者队列中验证量表,并开发交互式应用。

主要发现

  • aSAH患者治疗后抑郁发生率为29.6%(152/514)。
  • 与评分0分者相比,低风险组(1分)抑郁风险无显著增加(RR=0.89,95%CI 0.59-1.33,p=0.71)。
  • 中风险组(2-3分)抑郁风险显著增加(RR=1.78,95%CI 1.34-2.37,p<0.001)。
  • 高风险组(4-5分)抑郁风险显著增加(RR=2.29,95%CI 1.28-4.09,p<0.001)。

关键数值与推荐

  • 量表包括4个特征:吸烟(2分)、慢性阻塞性肺疾病(1分)、糖尿病(1分)、非囊状动脉瘤类型(1分)。
  • 评分1分为低风险,2或3分为中风险,4或5分为高风险。

临床怎么用

  • 可使用该5分制评分在出院时对aSAH患者进行抑郁风险分层。
  • 交互式应用可辅助出院咨询,帮助识别中高风险患者并加强随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A method for identification of chronic depression after aneurysmal subarachnoid hemorrhage (aSAH), risk stratification, and counseling is needed. This study aimed to develop a scoring system for post-aSAH depression and a user interface to supplement discharge counseling for patients. METHODS: Based on a published prediction model for posttreatment depression risk among aSAH patients, a scale was developed using the beta coefficients of the final predictive model. The 5-point scale was based on 4 characteristics: tobacco use (2 points), chronic obstructive pulmonary disease (1 point), diabetes (1 point), and nonsaccular aneurysm type (1 point). A score of 1 was defined as low risk, a score of 2 or 3 was defined as medium risk, and a score of 4 or 5 was defined as high risk. The scale was then validated in a cohort of 514 patients treated at a single center. An interactive application was developed. RESULTS: The rate of posttreatment depression among aSAH patients was 29.6% (152 of 514). The low-risk group had a nonsignificant increase in depression risk (relative risk [RR] [95% CI] = 0.89 [0.59-1.33], p = 0.71) compared with those with a score of 0. Significant increases in depression risk were found in the medium-risk (RR [95% CI] = 1.78 [1.34-2.37], p < 0.001) and high-risk (RR [95% CI] = 2.29 [1.28-4.09], p < 0.001) groups. CONCLUSIONS: A substantial percentage of patients in our cohort experienced major depressive disorder symptoms after aSAH treatment. An easy-to-use prediction and risk stratification tool for posttreatment depression among aSAH patients is available.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Koester SW, Hoglund BK, Hartke JN, et al. Depression after aneurysmal subarachnoid hemorrhage: development of a screening tool and discharge user interface. Acta Neurochir (Wien). 2025. PMID: 40553207. doi:10.1007/s00701-025-06567-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。